Bids Are Invited For Price Registration For The Possible Supply Of Antineoplastic, Controlled And Clinical Medicines (Sei Nº 0040610232.000028/2024-35)

(3243397) - Mercaptopurine - Concentration/Dosage 50 Mg, Tablet Pharmaceutical Form, Oral Administration Route, (3167984) - Methotrexate - Concentration/Dosage 2.5 Mg, (3242072) - Mitoxantrone - Concentration/Dosage 2 Mg/Ml, Form Pharmaceutical Solution Injectable, Vial-Ampule Presentation Form, Intravenous Administration Route, (3167437) - Methadone, Hydrochloride - Concentration/Dosage 5 Mg, (3169154) - Morphine, Sulfate - Concentration/Dosage 10 Mg, (3376346) - Pamidronate Disodium - Concentration /Dosage 90 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, (4823478) - Peg-Asparaginase - Concentration/Dosage 750 U/Ml, Pharmaceutical Form Injectable Solution, Parenteral Route Of Administration, (3198260) - Pethidine, Hydrochloride - Concentration/Dosage 50 Mg/ Ml, Shape Ampoule Presentation, (3180662) - Rasburicase - Concentration/Dosage 1.5 Mg/Ml, Presentation Form Ampoule Bottle + Diluent, (3362175) - Salmeterol, Xinafoate + Fluticasone, Propionate - Concentration/Dosage 25 Mcg + 125 Mcg Respectively, Form Aerosol Pharmaceuticals, Form Presentation Spray Bottle, Inhalation Route Of Administration, (3208079) - Sulfadiazine - Concentration/Dosage 500 Mg, (3243346) - Thioguanine - Concentration/Dosage 40 Mg, (3086224) - Tiotropium, Bromide - Concentration/Dosage 2.5 Mcg/ Dose, Form Farmaceutica Inhalation Solution, Presentation Form Bottle + Inhaler, (5245923) - Tiotropium Monohydrate, Bromide + Olodaterol, Hydrochloride - Concentration/Dosage 2.5 Mcg + 2.5 Mcg Respectively, (3243311) - Tretinoin - Concentration/Dosage 10 Mg , Capsule Pharmaceutical Form